EC Pharmacology and Toxicology

Outside of the traditional realm of plant toxicology, the field is increasingly intersecting with the current concerns of global health, the environment, and biotechnology. One of the key aspects of this is the emerging realization of the interindividual variability of the response to plant-derived toxins. Polymorphism of the drug metabolizing enzymes, transporters, and defense mechanisms may also play an important role in the response of the individual to the plant-derived toxins. The differences in the activity of the different isoenzymes of cytochrome P450, glutathione-S-transferases, etc., may also explain the differences in the toxicity of the plant-derived toxins in different individuals, as some individuals may show severe signs of toxicity, while others may not display any signs of toxicity even after the same conditions of exposure. This is an emerging area in the field of personalized toxicology.

In parallel, the human microbiome has also emerged as an important player in the modulation of plant toxicity. The gut microbiota may metabolize phytochemicals to either more or less toxic metabolites, depending on the direction of biotransformation. For example, the biotransformation of glycosides may produce the more toxic aglycone, or it may detoxify the more toxic compound before absorption. This tripartite relationship between plant compounds, host biology, and the microbiota represents an emerging area of research that has tremendous implications for both the field of toxicology and pharmacology.

Another area of plant science that is rapidly advancing is the application of artificial intelligence and computational toxicology. In this area, there has been an increased application of machine learning and other computer-aided models for the prediction of plant-derived chemical toxicities. This has been beneficial for the high-throughput screening of plant chemical libraries, thereby enabling the discovery of both toxic and non-toxic plant-derived compounds. In addition, these computer-aided models have also been beneficial for the discovery of plant-derived compounds with potential therapeutic applications. This has been possible through the application of quantitative structure-activity relationship (QSAR) and network pharmacology models.

Furthermore, the term "mixture toxicity" is increasingly coming into focus in the field of plant toxicology. In pharmacological studies, which are generally conducted with individual compounds, the situation is different when it comes to the actual exposure of organisms to plant products, as they are mixtures of active ingredients, which may act synergistically, additively, or antagonistically, producing unpredictable effects. Herbal formulations, polyherbal formulations, and supplements are all examples of mixtures of plant products, and the aspect of toxicity is a complex issue that has not been dealt with appropriately using appropriate techniques that are sufficiently advanced in dealing with the complexity of the issue.

From an evolutionary and ecological point of view, plant toxins may be regarded as an adaptive strategy that is developed in response to environmental pressures. This evolutionary point of view may provide important insights with regard to the rationale behind the synthesis of certain plant toxins and the manner in which their concentrations may be modulated in response to environmental factors. Climate change, for example, is expected to influence the pattern and concentration of certain plant toxins. In this regard, global warming, increased concentrations of CO₂, and precipitation patterns are expected to enhance the synthesis of certain secondary metabolites, thereby posing a potentially increased toxicological risk.

Furthermore, there is an urgent need to incorporate plant toxicology into both science and public health policies. This is particularly true since, despite the fact that the use of herbal products has gained popularity, regulation has not yet caught up with the science. As a result, there has been inconsistency in the quality, safety, and efficacy standards. Development of pharmacovigilance systems for herbal medicines, standardized systems for toxicity testing, as well as international risk assessment standards, are some of the processes that would be crucial in the future. These processes would largely depend on the cooperation of toxicologists, pharmacologists, ethnobotanists, and policymakers.

Educational efforts are also necessary in the development of the field. Incorporation of the field of plant toxicology in the medical, pharmaceutical, and life sciences educational curriculum may improve the awareness of future medical practitioners and scientists. This may reduce the cases of intoxication with plant products and improve the rational use of herbal medicine.

Lastly, there is a unique opportunity in plant toxicology to challenge the long-held belief that there is a dichotomy between “natural” and “synthetic” chemicals. The idea that “natural” is the same as “safe” is no longer supported by the evidence that many plant chemicals have significant toxic activities. In addition, some of the most effective drugs have been derived from toxic plant chemicals that have been scientifically examined and controlled.

In conclusion, the future of the field of plant toxicology is one that integrates the various scientific disciplines and addresses the complex challenges of the real world. By harnessing the innovations in the field of molecular biology, systems toxicology, computational modeling, and the environmental sciences, the field of plant toxicology is sure to make significant strides in the fields of medicine and public health. As the global dependence on the therapeutic uses of plant products continues to expand, the need to expand the knowledge of the toxicological profile of such products will be essential-not only to avoid adverse effects but also to harness the full therapeutic benefit of such products in a safe and controlled manner.